Literature DB >> 3997419

Quantitative vitreous fluorophotometry applying a mathematical model of the eye.

H Lund-Andersen, B Krogsaa, M la Cour, J Larsen.   

Abstract

A slit-lamp fluorophotometric method is presented that permits calculation of a blood-retinal barrier permeability to fluorescein (P) and a diffusion coefficient for fluorescein in the vitreous body (D). The calculations are performed by relating the time course of the free--not protein bound--fluorescein concentration in the bloodstream with the fluorescein concentration profile in the vitreous body. The combination is performed automatically on a computer by applying a simplified mathematical model of the eye. P refers to the area of the barrier of the model eye. In a group of six normal persons, the mean P was (1.1 +/- 0.4) X 10(-7) cm/sec (mean +/- SD), while in six diabetic patients with background retinopathy and macular edema the mean P was (7.1 +/- 3.8 ) X 10(-7) cm/sec. The mean D was (7.4 +/- 3.4) X 10(-6) cm2/sec in the normal group and (9.6 +/- 2.0) X 10(-6) cm2/sec in diabetic patients, corresponding as a first approximation to free diffusion in water. Model calculations show that knowing the fluorescein concentration in the bloodstream is considerably significant for the calculation of the permeability, contributing factors up to 50%. For the low-permeation situation, subtraction of the preinjection scan contributes a factor of 50% for both permeability and diffusion coefficient. The exact placement in the vitreous body of the concentration profile, by applying a formalism that transforms slit-lamp movement to intraocular distance, contributes a factor of 20% on the diffusion coefficient. The permeability obtained with the model can be calculated as the ratio between area of vitreous and plasma fluorescein concentration curves within 20%. Active transport of fluorescein across the blood-retinal barrier in the direction of vitreous to blood does not seem to be significant within the first 2 hr after fluorescein injection.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3997419

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  14 in total

1.  Protective effect of captopril on the blood-retina barrier in normotensive insulin-dependent diabetic patients with nephropathy and background retinopathy.

Authors:  M Larsen; E Hommel; H H Parving; H Lund-Andersen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

2.  Computer modeling of drug delivery to the posterior eye: effect of active transport and loss to choroidal blood flow.

Authors:  Ram K Balachandran; Victor H Barocas
Journal:  Pharm Res       Date:  2008-08-05       Impact factor: 4.200

3.  Localised blood-retinal barrier leakage and retinal light sensitivity in diabetic retinopathy.

Authors:  T Bek; H Lund-Andersen
Journal:  Br J Ophthalmol       Date:  1990-07       Impact factor: 4.638

4.  Permeability of the blood-retinal barrier in healthy humans. European Concerted Action on Ocular Fluorometry.

Authors:  H J Van Schaik; B Heintz; M Larsen; E Leite; V Rosas; R Schalnus; J A Van Best
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-10       Impact factor: 3.117

5.  Calculation of the permeability of the blood-retinal barrier to fluorescein.

Authors:  H Lund-Andersen; B Krogsaa; J Larsen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1985       Impact factor: 3.117

6.  Passive permeability and outward active transport of fluorescein across the blood-retinal barrier in early ARM.

Authors:  B Moldow; M Larsen; B Sander; H Lund-Andersen
Journal:  Br J Ophthalmol       Date:  2001-05       Impact factor: 4.638

7.  Diabetic macular oedema: a comparison of vitreous fluorometry, angiography, and retinopathy.

Authors:  B Sander; M Larsen; C Engler; C Strøm; B Moldow; N Larsen; H Lund-Andersen
Journal:  Br J Ophthalmol       Date:  2002-03       Impact factor: 4.638

8.  Diabetic macular oedema: the effect of photocoagulation on fluorescein transport across the blood-retinal barrier.

Authors:  B Sander; M Larsen; C Engler; B Moldow; H Lund-Andersen
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

9.  Blood-retina barrier permeability and its relation to the progression of diabetic retinopathy in type 1 diabetics. An 8-year follow-up study.

Authors:  C Engler; B Krogsaa; H Lund-Andersen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

10.  Differential spectrofluorometry in the human vitreous: blood-retina barrier permeability to fluorescein and fluorescein glucuronide.

Authors:  M Larsen; P Dalgaard; H Lund-Andersen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.